Technical Feasibility Demonstrated for Swine Disease Resistance Test
OTTAWA — PharmaGap, C.C.S.I., and PEI Pork have successfully demonstrated that the Swine Disease Resistance Test (SDR) effectively measures the immuno responsiveness of individual pigs.
Need a Product or service?
|
|
Through a small blood sample, stronger pigs may be selected for their innate disease
resistance traits, thereby expecting to improve the overall health of swine herds and to increasing their productivity.
The test is considered of a great interest by animal geneticists in order
to develop new lineages of more disease resistant pigs. Another potential
benefit is the possible reduction in the need for antibiotics, which would be
welcomed by the medical community and consumers alike.
The project was aided by a financial contribution from the National
Research Council's Industrial Research Assistance Program (IRAP).
The original participants, and others associated with the Industry, are
currently planning further development for commercialization purposes.
Participants and terms for this phase will be announced upon agreement
finalization.
The swine industry in North America spends annually about US $1.5 B in
health care. Such a test is believed to help in reducing these costs and
increase productivity in all segments of the industry.
Source: PRNewswire-FirstCall - 13th May 2003